Forecast: Imports of Pharmaceutical Products in China

The imports of pharmaceutical products in China have shown a steady increase from 2013 to 2023, standing at 49.86 Billion US Dollars in 2023. Over the last two years, the year-on-year variations were 8.36% in 2022 and 9.91% in 2023. The last five years have recorded an average annual growth rate (CAGR) of 12.29%, indicating robust growth in this sector.

Future trends to watch for:

• The projected CAGR for the next five years (2024-2028) is 5.71%, suggesting a deceleration in the growth rate compared to the previous period.
• Despite the slower growth, the total forecasted growth rate of 31.98% over the next five years points to continued expansion and increasing demand for pharmaceutical products in China.
• Factors such as aging population, healthcare reforms, and technological advancements in the pharmaceutical industry are likely to drive this growth.